Quality of Life in the Tube Versus Trabeculectomy Study

the Tube Versus Trabeculectomy Study Group

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Purpose To report the vision-specific quality-of-life (QoL) outcomes in the Tube Versus Trabeculectomy (TVT) Study. Design Multicenter randomized clinical trial. Methods SETTING: Seventeen clinical centers. STUDY POPULATION: Patients 18–85 years of age with medically uncontrolled glaucoma who had previous cataract and/or glaucoma surgery. INTERVENTIONS: Tube shunt (350-mm2 Baerveldt glaucoma implant) or trabeculectomy with MMC. MAIN OUTCOME MEASURES: Vision-specific QoL using the NEI VFQ-25 and estimation of minimally important differences (MID) were the main outcome measures. Cross-sectional distribution- and anchor-based approaches were used to estimate MID. Clinical anchor measures included the mean deviation (MD) and logMAR visual acuity (VA) measurements. Clinically significant changes in anchor were defined as ≥2 dB MD and ≥0.2 logMAR. Results No significant differences in composite scores were observed between treatment groups, and no significant change in scores were seen over time. Mean (SD; range) values of clinical anchors at baseline were −16.6 (9.3; −32 to −0.5) dB for the surgical eye and 0.2 (0.3; −0.1 to 1.3) logMAR VA in the better-vision eye. For anchor-based cross-sectional analysis, composite score MID (95% CI) was 6.3 (4.6–7.9) for better-eye VA and 1.4 (0.9–1.9) for surgical eye MD. Distribution-based MID for the composite score was 6.0. Conclusions Trabeculectomy and tube shunt surgery had similar impact on patient-reported vision-specific QoL measured using the NEI VFQ-25. In this cohort of patients with advanced glaucoma, MIDs varied depending on the clinical anchor used. Distribution-based MIDs corresponded well with anchor-based MIDs based on VA measures. The MID values reported here may be useful for others wishing to interpret NEI VFQ-25 scores in their advanced glaucoma patient cohort.

Original languageEnglish (US)
Pages (from-to)228-235
Number of pages8
JournalAmerican Journal of Ophthalmology
Volume176
DOIs
StatePublished - Apr 1 2017

Fingerprint

Trabeculectomy
Glaucoma
Quality of Life
Visual Acuity
Glaucoma Drainage Implants
Cataract
Randomized Controlled Trials
Cross-Sectional Studies
Outcome Assessment (Health Care)

ASJC Scopus subject areas

  • Ophthalmology

Cite this

Quality of Life in the Tube Versus Trabeculectomy Study. / the Tube Versus Trabeculectomy Study Group.

In: American Journal of Ophthalmology, Vol. 176, 01.04.2017, p. 228-235.

Research output: Contribution to journalArticle

the Tube Versus Trabeculectomy Study Group. / Quality of Life in the Tube Versus Trabeculectomy Study. In: American Journal of Ophthalmology. 2017 ; Vol. 176. pp. 228-235.
@article{6198a49d2e5845c39e36348fce962c2d,
title = "Quality of Life in the Tube Versus Trabeculectomy Study",
abstract = "Purpose To report the vision-specific quality-of-life (QoL) outcomes in the Tube Versus Trabeculectomy (TVT) Study. Design Multicenter randomized clinical trial. Methods SETTING: Seventeen clinical centers. STUDY POPULATION: Patients 18–85 years of age with medically uncontrolled glaucoma who had previous cataract and/or glaucoma surgery. INTERVENTIONS: Tube shunt (350-mm2 Baerveldt glaucoma implant) or trabeculectomy with MMC. MAIN OUTCOME MEASURES: Vision-specific QoL using the NEI VFQ-25 and estimation of minimally important differences (MID) were the main outcome measures. Cross-sectional distribution- and anchor-based approaches were used to estimate MID. Clinical anchor measures included the mean deviation (MD) and logMAR visual acuity (VA) measurements. Clinically significant changes in anchor were defined as ≥2 dB MD and ≥0.2 logMAR. Results No significant differences in composite scores were observed between treatment groups, and no significant change in scores were seen over time. Mean (SD; range) values of clinical anchors at baseline were −16.6 (9.3; −32 to −0.5) dB for the surgical eye and 0.2 (0.3; −0.1 to 1.3) logMAR VA in the better-vision eye. For anchor-based cross-sectional analysis, composite score MID (95{\%} CI) was 6.3 (4.6–7.9) for better-eye VA and 1.4 (0.9–1.9) for surgical eye MD. Distribution-based MID for the composite score was 6.0. Conclusions Trabeculectomy and tube shunt surgery had similar impact on patient-reported vision-specific QoL measured using the NEI VFQ-25. In this cohort of patients with advanced glaucoma, MIDs varied depending on the clinical anchor used. Distribution-based MIDs corresponded well with anchor-based MIDs based on VA measures. The MID values reported here may be useful for others wishing to interpret NEI VFQ-25 scores in their advanced glaucoma patient cohort.",
author = "{the Tube Versus Trabeculectomy Study Group} and Aachal Kotecha and Feuer, {William J} and Keith Barton and Gedde, {Steven J}",
year = "2017",
month = "4",
day = "1",
doi = "10.1016/j.ajo.2017.01.019",
language = "English (US)",
volume = "176",
pages = "228--235",
journal = "American Journal of Ophthalmology",
issn = "0002-9394",
publisher = "Elsevier USA",

}

TY - JOUR

T1 - Quality of Life in the Tube Versus Trabeculectomy Study

AU - the Tube Versus Trabeculectomy Study Group

AU - Kotecha, Aachal

AU - Feuer, William J

AU - Barton, Keith

AU - Gedde, Steven J

PY - 2017/4/1

Y1 - 2017/4/1

N2 - Purpose To report the vision-specific quality-of-life (QoL) outcomes in the Tube Versus Trabeculectomy (TVT) Study. Design Multicenter randomized clinical trial. Methods SETTING: Seventeen clinical centers. STUDY POPULATION: Patients 18–85 years of age with medically uncontrolled glaucoma who had previous cataract and/or glaucoma surgery. INTERVENTIONS: Tube shunt (350-mm2 Baerveldt glaucoma implant) or trabeculectomy with MMC. MAIN OUTCOME MEASURES: Vision-specific QoL using the NEI VFQ-25 and estimation of minimally important differences (MID) were the main outcome measures. Cross-sectional distribution- and anchor-based approaches were used to estimate MID. Clinical anchor measures included the mean deviation (MD) and logMAR visual acuity (VA) measurements. Clinically significant changes in anchor were defined as ≥2 dB MD and ≥0.2 logMAR. Results No significant differences in composite scores were observed between treatment groups, and no significant change in scores were seen over time. Mean (SD; range) values of clinical anchors at baseline were −16.6 (9.3; −32 to −0.5) dB for the surgical eye and 0.2 (0.3; −0.1 to 1.3) logMAR VA in the better-vision eye. For anchor-based cross-sectional analysis, composite score MID (95% CI) was 6.3 (4.6–7.9) for better-eye VA and 1.4 (0.9–1.9) for surgical eye MD. Distribution-based MID for the composite score was 6.0. Conclusions Trabeculectomy and tube shunt surgery had similar impact on patient-reported vision-specific QoL measured using the NEI VFQ-25. In this cohort of patients with advanced glaucoma, MIDs varied depending on the clinical anchor used. Distribution-based MIDs corresponded well with anchor-based MIDs based on VA measures. The MID values reported here may be useful for others wishing to interpret NEI VFQ-25 scores in their advanced glaucoma patient cohort.

AB - Purpose To report the vision-specific quality-of-life (QoL) outcomes in the Tube Versus Trabeculectomy (TVT) Study. Design Multicenter randomized clinical trial. Methods SETTING: Seventeen clinical centers. STUDY POPULATION: Patients 18–85 years of age with medically uncontrolled glaucoma who had previous cataract and/or glaucoma surgery. INTERVENTIONS: Tube shunt (350-mm2 Baerveldt glaucoma implant) or trabeculectomy with MMC. MAIN OUTCOME MEASURES: Vision-specific QoL using the NEI VFQ-25 and estimation of minimally important differences (MID) were the main outcome measures. Cross-sectional distribution- and anchor-based approaches were used to estimate MID. Clinical anchor measures included the mean deviation (MD) and logMAR visual acuity (VA) measurements. Clinically significant changes in anchor were defined as ≥2 dB MD and ≥0.2 logMAR. Results No significant differences in composite scores were observed between treatment groups, and no significant change in scores were seen over time. Mean (SD; range) values of clinical anchors at baseline were −16.6 (9.3; −32 to −0.5) dB for the surgical eye and 0.2 (0.3; −0.1 to 1.3) logMAR VA in the better-vision eye. For anchor-based cross-sectional analysis, composite score MID (95% CI) was 6.3 (4.6–7.9) for better-eye VA and 1.4 (0.9–1.9) for surgical eye MD. Distribution-based MID for the composite score was 6.0. Conclusions Trabeculectomy and tube shunt surgery had similar impact on patient-reported vision-specific QoL measured using the NEI VFQ-25. In this cohort of patients with advanced glaucoma, MIDs varied depending on the clinical anchor used. Distribution-based MIDs corresponded well with anchor-based MIDs based on VA measures. The MID values reported here may be useful for others wishing to interpret NEI VFQ-25 scores in their advanced glaucoma patient cohort.

UR - http://www.scopus.com/inward/record.url?scp=85013157952&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85013157952&partnerID=8YFLogxK

U2 - 10.1016/j.ajo.2017.01.019

DO - 10.1016/j.ajo.2017.01.019

M3 - Article

C2 - 28161049

AN - SCOPUS:85013157952

VL - 176

SP - 228

EP - 235

JO - American Journal of Ophthalmology

JF - American Journal of Ophthalmology

SN - 0002-9394

ER -